AgingResearch.NewsJoin free

Phase 4Recruiting

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

A Randomized Controlled Trial Comparing Mirabegron and Tamsulosin for Ureteral Stone Expulsion and Clinical Symptom Improvement

Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (Academic or other)
Enrollment
500 planned
Conditions
Ureteral Calculi
Interventions
Mirabegron; Tamsulosin
Ages
adults, older adults
Registry
NCT07310797

Full record on ClinicalTrials.gov

From the registry

This randomized controlled trial compares the efficacy and safety of four treatment strategies for ureteral stone expulsion: Mirabegron alone, Tamsulosin alone, a combination of both, and standard conservative care. Participants diagnosed with ureteral stones will be randomly assigned to one of these four groups. The primary objective is to evaluate the stone expulsion rate within 4 weeks. The study also assesses time to expulsion, pain intensity, analgesic use, and potential side effects.

Primary outcomes

  • Stone Expulsion Rate

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Started

  5. Registered